Commercializing RNAi Therapies With Alnylam's Tolga Tanguler
Business Of Biotech
00:00
Strategic Expansion in Biotech
This chapter explores the strategic approach of a biotech company in expanding its international presence, focusing on market selection and distribution logistics. It discusses the complexities of pricing strategies, value-based agreements with payers, and the importance of partnerships to manage ultra-rare diseases. Additionally, the chapter highlights the transition from rare diseases to broader public health challenges, emphasizing the need for effective communication and collaboration within the healthcare landscape.
Transcript
Play full episode
